KRBL Limited (KRBL.NS) Bundle
Curious whether KRBL Limited is a resilient growth story or a company navigating choppy waters? In Q1 FY26 the company posted revenue of ₹1,584 crore - a 32% year-on-year jump led by a 98% surge in export revenue - building on its record quarterly income of ₹1,690 crore in Q3 FY25 and full-year sales of ₹5,593.81 crore in FY25, while management targets over ₹6,000 crore for FY26 with export revenues of ₹1,700-1,800 crore; profitability shows mixed signals - gross margin improving to 25.7% in Q1 FY26 but EBITDA slipping to 12% in Q3 FY25 and PAT in Q3 at ₹133 crore - juxtaposed with a strengthening balance sheet: zero long-term debt as of March 2025 and net debt down from ₹901 crore to ₹92 crore, cash of ₹210 crore, operating cash flow hitting a record ₹960 crore in FY25, and shareholder funds rising to ₹5,240.31 crore; valuation sits near market reality with the share at ₹440.35 (Sept 10, 2025), EPS ₹20.80 and P/E ~21.2x, even as risks like a 7% decline in basmati export realizations, a lost Saudi distributor and government export bans test export momentum - against growth levers such as plans to invest ₹250 crore in three new plants, a stepped-up Europe/North America push, a new health brand and expansion to 4.15 lakh retail outlets; read on for a chapter-by-chapter breakdown of these figures and what they mean for investors.
KRBL Limited (KRBL.NS) - Revenue Analysis
KRBL Limited reported strong top-line momentum into FY26 driven largely by export recovery and volume growth. Q1 FY26 revenue jumped 32% year-on-year to ₹1,584 crore, helped by a 98% surge in export revenue. The company targets >₹6,000 crore in consolidated revenue for FY26, with export revenues forecast at ₹1,700-1,800 crore.- Q1 FY26 revenue: ₹1,584 crore (32% YoY growth)
- Q3 FY25 highest-ever quarterly revenue: ₹1,690 crore (+15% YoY)
- FY24-25 sales: ₹5,593.81 crore (+3.88% vs ₹5,384.69 crore in FY23-24)
- Export contribution: Q3 FY25 export revenue ₹567 crore (104% YoY); FY25 export rice volumes +17% YoY
- FY26 guidance: revenue >₹6,000 crore; export revenue expected ₹1,700-1,800 crore
| Period | Total Revenue (₹ crore) | YoY % | Export Revenue (₹ crore) | Export YoY % / Notes |
|---|---|---|---|---|
| Q3 FY25 | 1,690 | +15% | 567 | +104% |
| Q1 FY26 | 1,584 | +32% | (Export surged 98% YoY) | Export-led growth |
| FY24-25 (Full Year) | 5,593.81 | +3.88% | - | Export rice volumes +17% YoY despite challenges |
| FY26 (Target) | >6,000 | - | 1,700-1,800 (expected) | Management guidance |
- Export recovery: sharp YoY jump in export receipts (Q1 FY26 and Q3 FY25) is the primary revenue driver.
- Volume resilience: FY25 export rice volumes rose 17% despite a distributor loss in Saudi Arabia and government export bans impacting certain shipments.
- Seasonality and quarterly peaks: Q3 FY25 represents the highest quarterly revenue to date, indicating strong season/market execution.
- Guidance sensitivity: FY26 target (>₹6,000 crore) depends materially on achieving the projected ₹1,700-1,800 crore in exports.
KRBL Limited (KRBL.NS) - Profitability Metrics
- Gross Profit Margin: Q1 FY26 - 25.7% (up from 23.2% in Q1 FY25), driven by lower average basmati COGS.
- EBITDA Margin: Q3 FY25 - 12.0% (down from 14.1% in Q3 FY24), negatively impacted by higher freight costs.
- Profit After Tax (PAT): Q3 FY25 - ₹133 crore; PAT margin 7.8% (vs. ₹134 crore and 9.1% in Q3 FY24).
- Operating Profit Margin (OPM): Q4 FY25 - 15.51% (up from 13.53% in Q4 FY24).
- Net Profit Margin: Q2 FY26 - 9.3% (improved from 7.8% in Q1 FY26).
- Full Year FY25 Net Profit: declined 20.11% year-on-year, while operating profit margin remained positive.
| Metric | Period | Value | YoY / Note |
|---|---|---|---|
| Gross Profit Margin | Q1 FY26 | 25.7% | +2.5 pp vs Q1 FY25 (23.2%) |
| EBITDA Margin | Q3 FY25 | 12.0% | -2.1 pp vs Q3 FY24 (14.1%); freight cost headwinds |
| PAT | Q3 FY25 | ₹133 crore | PAT margin 7.8% (vs ₹134 cr / 9.1% in Q3 FY24) |
| Operating Profit Margin | Q4 FY25 | 15.51% | +1.98 pp vs Q4 FY24 (13.53%) |
| Net Profit Margin | Q2 FY26 | 9.3% | Improved from 7.8% in Q1 FY26 |
| Full Year Net Profit Change | FY25 (year ended Mar 2025) | -20.11% | Net profit decline despite positive OPM |
- Drivers improving margins: lower basmati COGS (Q1 FY26 gross margin lift), operational leverage in Q4 FY25.
- Pressures on margins: elevated freight and logistics costs (notably affecting Q3 FY25 EBITDA), commodity price volatility that can compress PAT.
- Trend signals: sequential recovery in net margin into Q2 FY26 (9.3%) after weaker Q1 FY26 (7.8%), suggesting partial stabilization.
KRBL Limited (KRBL.NS) - Debt vs. Equity Structure
KRBL Limited's balance-sheet profile through FY25 and into mid-2025 shows a marked shift toward equity-funded growth and sharply reduced leverage. The company reported zero long-term debt as of March 2025, while net debt fell substantially year-on-year and shareholder funds expanded, improving key solvency ratios.- Long-term debt: ₹0 crore as of March 2025.
- Net debt: ₹92 crore as of December 31, 2024 (down from ₹901 crore the prior year).
- Shareholder funds: ₹5,240.31 crore as of March 2025 (up from ₹4,857.91 crore a year earlier).
- Overall gearing ratio: 0.08x as of March 31, 2025 (vs. 0.11x in prior year).
- Net worth: ₹5,391 crore as of June 30, 2025.
- Total liabilities: ₹62,153 crore in FY25 vs. ₹59,270 crore in FY24 (+4.9%).
| Metric | Value | Reference Date / Period |
|---|---|---|
| Long-term debt | ₹0 crore | 31-Mar-2025 |
| Net debt | ₹92 crore | 31-Dec-2024 |
| Net debt (prior year) | ₹901 crore | 31-Dec-2023 |
| Shareholder funds | ₹5,240.31 crore | 31-Mar-2025 |
| Shareholder funds (prior year) | ₹4,857.91 crore | 31-Mar-2024 |
| Overall gearing ratio | 0.08x | 31-Mar-2025 |
| Overall gearing ratio (prior year) | 0.11x | 31-Mar-2024 |
| Net worth | ₹5,391 crore | 30-Jun-2025 |
| Total liabilities (FY25) | ₹62,153 crore | FY25 |
| Total liabilities (FY24) | ₹59,270 crore | FY24 |
KRBL Limited (KRBL.NS) - Liquidity and Solvency
KRBL's balance-sheet movements in FY25 show materially stronger liquidity and improving solvency metrics, underpinned by a sharp rise in cash, robust current assets and record operating cash flow.- Cash & cash equivalents: ₹210 crore in Mar‑2025 (₹24 crore in Mar‑2024) - ~775% year‑on‑year increase.
- Current assets: ₹5,239.11 crore in FY25, providing liquidity to fund working capital needs.
- Operating cash flow: ₹960 crore in FY25 - the highest on record, driven by favorable working capital movements.
- Current liabilities: ₹8,361 crore in FY25, down 9.1% from ₹9,195 crore in FY24.
- Total assets: ₹62,153 crore in FY25 vs ₹59,270 crore in FY24 (+4.9%).
- Fixed assets: ₹9,779 crore in FY25 vs ₹9,656 crore in FY24 (+1.3%).
| Metric | FY24 | FY25 | YoY change |
|---|---|---|---|
| Cash & cash equivalents (₹ crore) | 24 | 210 | +775% |
| Current assets (₹ crore) | - | 5,239.11 | - |
| Operating cash flow (₹ crore) | - | 960 | - |
| Current liabilities (₹ crore) | 9,195 | 8,361 | -9.1% |
| Total assets (₹ crore) | 59,270 | 62,153 | +4.9% |
| Fixed assets (₹ crore) | 9,656 | 9,779 | +1.3% |
- Current ratio (Current assets / Current liabilities): 5,239.11 / 8,361 ≈ 0.63 - reflects working‑capital intensity despite ample absolute current assets.
- Cash as % of current liabilities: 210 / 8,361 ≈ 2.5% - cash buffer improved materially from FY24 but remains a small portion of short‑term obligations.
KRBL Limited (KRBL.NS) - Valuation Analysis
KRBL's valuation profile for FY25 shows a mid‑range market valuation relative to its fundamentals, with key metrics suggesting the market prices the company at a modest premium to book and a P/E consistent with steady earnings expectations.- Share price (10 Sep 2025): ₹440.35 - nearly identical to InvestingPro fair value estimate of ₹440.34.
- EPS (FY25): ₹20.80 per share.
- Book value per share (FY25): ₹228.90.
- P/E ratio (FY25): ≈ 21.2x (calculated as 440.35 / 20.80).
- P/B ratio (FY25): ≈ 1.92x (calculated as 440.35 / 228.90).
- Dividend (final FY25): ₹3.50 per share → dividend yield ≈ 0.9%.
- Market capitalization (Dec 2025): ₹89.29 billion.
| Metric | Value | Calculation / Note |
|---|---|---|
| Share price (snapshot) | ₹440.35 | 10 Sep 2025 |
| InvestingPro fair value | ₹440.34 | Nearly identical to market price |
| EPS (FY25) | ₹20.80 | Reported FY25 |
| Book value per share (FY25) | ₹228.90 | Reported FY25 |
| P/E (FY25) | 21.2x | 440.35 ÷ 20.80 |
| P/B (FY25) | 1.92x | 440.35 ÷ 228.90 |
| Dividend (final FY25) | ₹3.50 | Declared for FY25 |
| Dividend yield | 0.9% | 3.50 ÷ 440.35 |
| Market capitalization | ₹89.29 billion | As of Dec 2025 |
- Price vs fair value: Market price aligning with InvestingPro's fair value implies limited upside from re‑rating alone unless fundamentals improve or estimates change.
- Earnings multiple: A ~21x P/E reflects expectations of steady earnings growth rather than high growth - investors should compare this to rice/consumer-packaged-goods peers for context.
- Balance sheet buffer: P/B near 1.9x indicates the market values the business at a significant premium to book but not at an extreme multiple; tangible capital and inventory cycles matter for rice exporters.
- Income return: Low dividend yield (~0.9%) suggests KRBL is not primarily an income stock; total returns will rely more on capital appreciation and earnings growth.
- Market size: ₹89.29B market cap places KRBL in mid‑cap territory - liquidity and index inclusion implications are relevant for institutional flows.
KRBL Limited (KRBL.NS) - Risk Factors
Key risk vectors for KRBL Limited span commodity-price pressures, export-market disruptions, working-capital stress and margin compression driven by input and logistics costs.
- Basmati export realizations fell ~7% in Q3 FY25, reflecting international price pressure and weakening premium for branded/packet rice.
- Export disruptions: loss of a distributor in Saudi Arabia plus intermittent government export bans have constrained export growth and channel stability.
- Working-capital strain: debtors turnover declined to 11.62 times in H1 FY26, indicating longer receivable collection cycles and potential cash conversion delays.
- Domestic demand/portfolio effects: domestic revenue fell ~4% in Q3 FY25 due to regional rice portfolio optimization and temporary softness in bulk-pack realizations.
- Margin erosion: higher-cost paddy procurement pushed OPM down to 12.06% in FY25 from 14.90% in FY24.
- Profitability impact from logistics: net profit margin dropped to 7.8% in Q3 FY25 versus 9.1% in Q3 FY24, with elevated freight costs cited as a material headwind.
| Metric | Period | Value / Change | Implication |
|---|---|---|---|
| Basmati export realizations | Q3 FY25 | Down 7% | Price pressure; revenue per ton contraction |
| Domestic revenue | Q3 FY25 | Down 4% | Portfolio optimization & bulk-pack softness |
| Debtors turnover | H1 FY26 | 11.62 times | Longer receivable days, liquidity risk |
| Operating profit margin (OPM) | FY25 vs FY24 | 12.06% vs 14.90% | Margin compression from higher-cost paddy |
| Net profit margin | Q3 FY25 YoY | 7.8% vs 9.1% | Freight & logistics increased costs |
| Channel risk | Ongoing | Distributor loss, export bans | Concentrated market vulnerability |
- Operational sensitivity: margins remain exposed to paddy procurement price spikes, freight volatility and policy-driven export restrictions.
- Counterparty and geographic concentration: losing key distributors (e.g., in Saudi Arabia) amplifies revenue volatility in key export markets.
- Liquidity and funding: slower debtor turns (11.62x in H1 FY26) may necessitate higher working-capital financing if collection trends persist.
For investor context and ownership/transaction details, see: Exploring KRBL Limited Investor Profile: Who's Buying and Why?
KRBL Limited (KRBL.NS) Growth Opportunities
KRBL is actively positioning itself beyond traditional Basmati rice leadership by pursuing geographic expansion, product diversification and retail penetration to capture higher-margin segments and global market share.- Geographic expansion: Targeting Europe and North America through collaborations and new product launches to become a global leader in Basmati rice.
- Manufacturing scale-up: Planned capex of ₹250 crore to set up three new plants in Gujarat, Karnataka and Madhya Pradesh over the next two years.
- Product diversification: Launched Uplife, a health-focused brand entering health & wellness categories (e.g., healthy edible oils).
- Revenue mix shift: Strategic aim to raise revenue share from non-rice products to reduce commodity concentration risk.
- Export momentum: Export revenue surged 98% in Q1 FY26, signalling strong international demand traction.
- Retail expansion: Retail footprint reached 4.15 lakh outlets, a net increase of ~40,000 stores year‑on‑year, improving consumer reach and brand visibility.
| Initiative | Metric / Detail |
|---|---|
| Planned capex | ₹250 crore (next 2 years) |
| New plants | 3 plants (Gujarat, Karnataka, Madhya Pradesh) |
| Export growth | Export revenue +98% in Q1 FY26 |
| Retail reach | 4.15 lakh outlets (+40,000 YoY) |
| New brand | Uplife - health & wellness (healthy edible oils) |
| Non-rice revenue ambition | Aim to increase share (specific target not disclosed) |
| International focus | Europe & North America expansion via collaborations/new products |

KRBL Limited (KRBL.NS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.